Editorial: Exploring modern approaches to address critical care challenges in risk stratification for cardiology.

Competing Interests: TAZ reports research grants from Boehringer Ingelheim; honoraria for serving on advisory boards from Bayer AG and Boehringer Ingelheim; personal fees from Alkem Lab. Ltd, AstraZeneca, Bayer AG, Boehringer Ingelheim, and Sun Pharmaceutical Industries, and educational grants from Eli Lilly and Company. RHMF reports research grants and personal fees from AstraZeneca, Bayer, Servier, and Apsen; and research grants (received from his institution) from Pfizer and Libbs. AFJ reports educational grants from Boehringer Ingelheim, AstraZeneca, Novartis and Merck sharp and Dohme; honoraria for serving on advisory boards from Merck sharp and Dohme. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.